Alaunos Therapeutics Inc
$ 2.73
-1.80%
22 Apr - close price
- Market Cap 6,611,500 USD
- Current Price $ 2.73
- High / Low $ 2.85 / 2.73
- Stock P/E N/A
- Book Value 1.27
- EPS -2.15
- Next Earning Report f
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.92 %
- ROE -1.98 %
- 52 Week High 5.48
- 52 Week Low 1.67
About
Alaunos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on discovering, acquiring, developing and commercializing a portfolio of immuno-oncology therapies to treat cancer patients. The company is headquartered in Houston, Texas.
Analyst Target Price
$1.75
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-14 | 2025-08-14 | 2025-05-13 | 2025-03-31 | 2024-11-12 | 2024-08-14 | 2024-04-01 | 2024-03-05 | 2023-11-14 | 2023-08-14 | 2023-05-10 | 2023-03-07 |
| Reported EPS | -0.55 | -0.63 | -0.6701 | -0.4634 | -0.7038 | -0.7051 | -0.49 | -0.49 | -0.04 | -0.04 | -0.04 | -0.04 |
| Estimated EPS | 0 | None | None | None | None | None | -0.45 | -0.45 | -0.04 | -0.04 | -0.04 | -0.07 |
| Surprise | -0.55 | 0 | 0 | 0 | 0 | 0 | -0.04 | -0.04 | 0 | 0 | 0 | 0.03 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | -8.8889% | -8.8889% | 0% | 0% | 0% | 42.8571% |
Next Quarterly Earnings
| Apr 2026 | |
|---|---|
| Reported Date | f |
| Fiscal Date Ending | o |
| Estimated EPS | r |
| Currency | m |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
